Pediatric hematology/oncology physician and nurse practitioner attitudes towards the COVID-19 vaccines: A qualitative study.

Autor:	Miller ME; Department of Adult Hematology/Oncology, Indiana University School of Medicine, Indianapolis, United States., Rahim MQ; Department of Pediatric Hematology/Oncology, Indiana University School of Medicine, Indianapolis, United States., Coven SL; Department of Pediatric Hematology/Oncology, Indiana University School of Medicine, Indianapolis, United States., Jacob SA; Department of Pediatric Hematology/Oncology, Indiana University School of Medicine, Indianapolis, United States., Zimet GD; Department of Pediatrics, Division of Adolescent Medicine, Indiana University School of Medicine, Indianapolis, United States., Meagher CG; Department of Pediatrics, Division of Adolescent Medicine, Indiana University School of Medicine, Indianapolis, United States., Ott MA; Department of Pediatrics, Division of Adolescent Medicine, Indiana University School of Medicine, Indianapolis, United States.; IU Center for Bioethics, Indiana University School of Medicine, Indianapolis, United States.
Jazyk:	angličtina
Zdroj:	Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (5), pp. 2048560. Date of Electronic Publication: 2022 Mar 28.
DOI:	10.1080/21645515.2022.2048560
Abstrakt:	As of 05/28/2021, SARS-CoV-2 (COVID-19) had caused 3.9 million infections in the United States (US) pediatric population since its discovery in December of 2019. The development and expansion of vaccination has markedly changed the shape of the epidemic. In this qualitative study, we report on pediatric hematology/oncology provider views on the COVID-19 vaccine prior to approval in the adolescent population <16 years of age. Results from interviews with 20 providers across the state of Indiana showed that most were supportive of the COVID-19 vaccine for healthy adults. However, the majority also expressed a need to see more data on the safety and effectiveness of COVID-19 vaccinations in pediatric hematology/oncology populations. While they recognized the public health importance of vaccination, their duty to protect their patients led to a need for more specific safety and efficacy data.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu